Medical/Pharmaceuticals

Xinhua Silk Road: 52nd Zhangshu National Traditional Chinese Materia Medica Trade Fair kicks off in E. China's Jiangxi

BEIJING, Oct. 20, 2021 /PRNewswire/ -- The 52nd Zhangshu National Traditional Chinese Materia MedicaTrade Fair opened in Zhangshu, a country-level city in eastChina's Jiangxi Province on Saturday.

2021-10-20 17:27 4277

A Hypercompact CRISPR Technology Developed by GenKOre is deemed a Potential Game Changer in Gene Therapy.

DAEJEON, South Korea, Oct. 20, 2021 /PRNewswire/ -- On September 2, 2021, a scientific paper from GenKOre on the new hypercompact CRISPR system called CRISPR/Cas12f-GE was published in an online issue of Nature Biotechnology (IF 54.9), one of the world's top-tier biotechnology journals.

2021-10-20 15:31 4246

Getinge Q3 Report 2021: "Strong order intake and our remediation measures completed in Germany"

GOTHENBURG, Sweden, Oct. 20, 2021 /PRNewswire/ -- "Organic order intake increased by more than 20% in the third quarter, with a strong performance in all business areas and regions," says Mattias Perjos, President & CEO at Getinge. "Our cash flow remains strong, meaning that we have strengthened ...

2021-10-20 15:19 4219

Action for bone health is needed now more than ever, urges IOF

NYON, Switzerland, Oct. 20, 2021 /PRNewswire/ -- A backlog in osteoporosis assessments, treatment delays, and sedentary indoor lifestyles: these are just several ways in which the Covid-19 pandemic has impacted bone health and disrupted global osteoporosis care. Osteoporosis is a common bone dis...

2021-10-20 13:30 4157

Bill & Melinda Gates Foundation Commits up to $120 Million to Accelerate Access to COVID-19 Drug for Lower-Income Countries, Calls on Other Donors to Mobilize Resources

Financial commitment aims to secure dedicated, low-cost supply of molnupiravir, if the drug is authorized by regulators; builds on long-term efforts to increase access to tests, treatments, vaccines SEATTLE, Oct. 20, 2021 /PRNewswire/ -- The Bill & Melinda Gates Foundation announced today a comm...

2021-10-20 13:29 3204

Phillips-Medisize Increases Global Manufacturing Capacity, Capabilities and Collaborations to Drive Drug Delivery, Diagnostic and MedTech Innovations

- Medical and pharmaceutical solutions leader poised to scale manufacturing from new and expanded production facilities and R&D centers inPoland, China and U.S. - End-to-end capabilities optimize design, development and manufacturing of world-class healthcare products and solutions while reducin...

2021-10-20 10:00 4096

CStone received China NMPA IND acceptance for lorlatinib in Chinese patients with ROS1-positive advanced NSCLC

SUZHOU, China, Oct. 20, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology therapies and precision medicines, today announced that the investigational new drug (...

2021-10-20 08:00 4722

Insilico Medicine Appoints Business Leader, Michelle Chen, as Chief Business Officer

HONG KONG and NEW YORK, Oct. 19, 2021 /PRNewswire/ -- Insilico Medicine, an end-to-end AI-powered drug discovery company, today announced the appointment of Dr.Michelle Chen to the company's position of Chief Business Officer.  In this role, Dr. Chen will oversee the company's corporate strategie...

2021-10-19 23:30 4300

Excelra Announces Addition of Sudip Nandy to its Board of Directors

HYDERABAD, India, Oct. 19, 2021 /PRNewswire/ -- Excelra, a leading Data and Analytics provider for Life Science organizations, announced the appointment of Sudip Nandy to the company's board of directors effective 1st October 2021. Mr. Nandy is an acclaimed business leader with over 30 years of e...

2021-10-19 21:00 8433

Qiming's Portfolio Company Microtech Medical Lists on Main Board of HKEx

SHANGHAI, Oct. 19, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Microtech Medical (SEHK:2235), a leading Chinese diabetes management medical device maker, today listed on the main board of the Hong Kong Stock Exchange. The issue price isHK$ 30.5 per share. The stock opened a...

2021-10-19 14:07 5268

Prenetics To Be The Exclusive RT-PCR COVID-19 Testing Partner For The Standard Chartered Hong Kong Marathon 2021

HONG KONG, Oct. 19, 2021 /PRNewswire/ -- Prenetics (the "Company"), a global leader in genomic and diagnostic testing, announced today it has been appointed as the official RT-PCR COVID-19 testing partner for the Standard Chartered Hong Kong Marathon 2021, which is set to take place onOctober 24....

2021-10-19 09:00 3251

CARB-X Funds the 3rd Round of Debiopharm's Targeted Antibiotic Program to Combat Resistant N. gonorrhoeae Infections

LAUSANNE, Switzerland and BOSTON, Oct. 19, 2021 /PRNewswire/ -- Debiopharm ( www.debiopharm.com ), a Swiss-based global biopharmaceutical company announced today having been awarded the third phase funding to advance the development of its antibiotic program, Debio 1453...

2021-10-19 09:00 2332

DiscGenics Honored by Goldman Sachs for Entrepreneurship

Chairman and CEO Flagg Flanagan Among 100 Most Intriguing Entrepreneurs at 2021 Builders + Innovators Summit SALT LAKE CITY, Oct. 19, 2021 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and ...

2021-10-19 07:34 3224

Australian businesses invited to advance the future of healthcare technologies in the Medtronic APAC Innovation Challenge

SYDNEY, Oct. 19, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in healthcare technology, invites Australian businesses to participate in the newly launchedMedtronic APAC Innovation Challenge (MAIC). Providing an opportunity for innovators in the region to pitch and advance the...

2021-10-19 06:51 4403

kpNext(TM) Klöckner Pentaplast Launches Its New Recylable Pet Blister Film

SUZHOU, China, Oct. 18, 2021 /PRNewswire/ -- Klöckner Pentaplast (kp), a leading global manufacturer of high barrier protective packaging solutions with industry-leading use of recycled content material, has launched kpNext™, its first-to-market innovation in recyclable PET blister films. kpNext ...

2021-10-18 18:36 3588

Artificial Intelligence to Boost the Global Wound Care Market by 2026 with Minimal Intervention Solutions

The global wound care solutions market is estimated to garner $30.5 billion in revenue by 2026 at a compound annual growth rate of 6.7%, finds Frost & Sullivan SAN ANTONIO, Oct. 18, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, Global Wound Care Solutions and New-age Technology Growth ...

2021-10-18 15:03 1782

Mentice receives order of total SEK 7.0 million from ABBOTT

STOCKHOLM, Oct. 18, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, has through its fully owned subsidiary Mentice Inc entered into an agreement withABBOTT Inc. to provide simulation ...

2021-10-18 14:54 2094

Nanoform convenes EGM to elect Jeanne Thoma as board member

HELSINKI, Finland, Oct. 18, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform "), an innovative nanoparticle medicine enabling company, will convene an extraordinary general meeting (EGM) onNovember 17, 2021, at 14:00 EEST to elect Jeanne Thoma as a new board member. The notice to the EGM was p...

2021-10-18 14:06 2190

Alphamab Oncology Completed Enrollment in the First Pivotal Phase III Clinical Study of the Bispecific Antibody KN046

* ENREACH-LUNG-01 is a multi-center, randomized, double-blind, placebo-controlled phase III clinical study of KN046 combined with platinum-containing chemotherapy in patients with advanced unresectable or metastatic squamous NSCLC. Enrollment of all 482 patients has been completed according to...

2021-10-18 10:19 3248

Innovent Announces ORIENT-31, a Phase 3 Study of Sintilimab in Patients with EGFR-Mutated Nonsquamous Non-Small Cell Lung Cancer with Prior EGFR-TKI Treatment, Has Met Primary Endpoint

SAN FRANCISCO and SUZHOU, China, Oct. 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2021-10-18 08:00 5521